» Articles » PMID: 35029144

DunedinPACE, a DNA Methylation Biomarker of the Pace of Aging

Abstract

Background: Measures to quantify changes in the pace of biological aging in response to intervention are needed to evaluate geroprotective interventions for humans. Previously, we showed that quantification of the pace of biological aging from a DNA-methylation blood test was possible (Belsky et al., 2020). Here, we report a next-generation DNA-methylation biomarker of Pace of Aging, DunedinPACE (for Pace of Aging Calculated from the Epigenome).

Methods: We used data from the Dunedin Study 1972-1973 birth cohort tracking within-individual decline in 19 indicators of organ-system integrity across four time points spanning two decades to model Pace of Aging. We distilled this two-decade Pace of Aging into a single-time-point DNA-methylation blood-test using elastic-net regression and a DNA-methylation dataset restricted to exclude probes with low test-retest reliability. We evaluated the resulting measure, named DunedinPACE, in five additional datasets.

Results: DunedinPACE showed high test-retest reliability, was associated with morbidity, disability, and mortality, and indicated faster aging in young adults with childhood adversity. DunedinPACE effect-sizes were similar to GrimAge Clock effect-sizes. In analysis of incident morbidity, disability, and mortality, DunedinPACE and added incremental prediction beyond GrimAge.

Conclusions: DunedinPACE is a novel blood biomarker of the pace of aging for gerontology and geroscience.

Funding: This research was supported by US-National Institute on Aging grants AG032282, AG061378, AG066887, and UK Medical Research Council grant MR/P005918/1.

Citing Articles

Epigenetic entropy, social disparity, and health and lifespan in the Women's Health Initiative.

Mozhui K, Starlard-Davenport A, Sun Y, Shadyab A, Casanova R, Thomas F medRxiv. 2025; .

PMID: 40061325 PMC: 11888519. DOI: 10.1101/2025.02.21.25322696.


Ambient outdoor heat and accelerated epigenetic aging among older adults in the US.

Choi E, Ailshire J Sci Adv. 2025; 11(9):eadr0616.

PMID: 40009659 PMC: 11864172. DOI: 10.1126/sciadv.adr0616.


How quickly are you ageing? What molecular 'clocks' can tell you about your health.

Ledford H Nature. 2025; 638(8052):874-876.

PMID: 40000869 DOI: 10.1038/d41586-025-00566-6.


Epigenetic Clock Analysis for National Institutes of Health Stroke Scale in Patients With Ischemic Stroke.

Jiang W, Shirai T, Otsuka I, Okazaki S, Tanifuji T, Horai T Neuropsychopharmacol Rep. 2025; 45(1):e70009.

PMID: 39985312 PMC: 11845873. DOI: 10.1002/npr2.70009.


New perspectives on DNA methylation modifications in ocular diseases.

Zong F, Jia D, Huang G, Pan M, Hu H, Song S Int J Ophthalmol. 2025; 18(2):340-350.

PMID: 39967986 PMC: 11754021. DOI: 10.18240/ijo.2025.02.19.


References
1.
Poulton R, Moffitt T, Silva P . The Dunedin Multidisciplinary Health and Development Study: overview of the first 40 years, with an eye to the future. Soc Psychiatry Psychiatr Epidemiol. 2015; 50(5):679-93. PMC: 4412685. DOI: 10.1007/s00127-015-1048-8. View

2.
Hagg S, Belsky D, Cohen A . Developments in molecular epidemiology of aging. Emerg Top Life Sci. 2021; 3(4):411-421. PMC: 7289014. DOI: 10.1042/ETLS20180173. View

3.
Elliott M, Caspi A, Houts R, Ambler A, Broadbent J, Hancox R . Disparities in the pace of biological aging among midlife adults of the same chronological age have implications for future frailty risk and policy. Nat Aging. 2021; 1(3):295-308. PMC: 8009092. DOI: 10.1038/s43587-021-00044-4. View

4.
Fisher H, Caspi A, Moffitt T, Wertz J, Gray R, Newbury J . Measuring adolescents' exposure to victimization: The Environmental Risk (E-Risk) Longitudinal Twin Study. Dev Psychopathol. 2015; 27(4 Pt 2):1399-416. PMC: 4778729. DOI: 10.1017/S0954579415000838. View

5.
Lu A, Quach A, Wilson J, Reiner A, Aviv A, Raj K . DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019; 11(2):303-327. PMC: 6366976. DOI: 10.18632/aging.101684. View